505 results on '"Wainwright C"'
Search Results
2. Re-engineering of the bid preparation process in an aircraft modification business
3. P170 Variability of intra-breath oscillometry in children with cystic fibrosis
4. P171 Feasibility of home-based oscillometry monitoring in paediatric cystic fibrosis
5. P089 FORMaT: Finding the Optimal Regimen for Mycobacterium abscessus Treatment. A randomised, multi-arm, adaptive platform trial
6. WS01.01 Clinical validation of automated vs manual PRAGMA-CF CT score in children with CF
7. WS03.03 Mental health and sleep quality in children receiving elexacaftor/tezacaftor/ivacaftor therapy
8. C-FOG : Life of Coastal Fog
9. 133 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: 144-week results of an open-label extension study
10. A Morphological Study of Gamma-Ray Burst Host Galaxies
11. Volume-dependence of Reactance as a Measure of Ventilation Inhomogeneity in Cystic Fibrosis
12. Measures of Ventilation Inhomogeneity in Children With Cystic Fibrosis: Intra-breath Oscillometry Vs. MBW
13. A SYSTEMATIC REVIEW AND META-ANALYSIS OF PATIENT-RECORDED OUTCOME MEASURES IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION: HOW GOOD IS GOOD ENOUGH?
14. Indian Ocean mean state biases and IOD behaviour in the CMIP6 multimodel ensemble
15. LABLE : A Multi-Institutional, Student-Led, Atmospheric Boundary Layer Experiment
16. 163 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children 6 years and older with cystic fibrosis and at least one F508del alleles: 96-week interim results from an open-label extension study
17. 183 Chest computed tomography assessment to monitor cystic fibrosis structural lung disease progression in bronchiectasis during late childhood and adolescence
18. 148 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: final results from a 192-week extension study.
19. Sources and dynamics of fluorescent particles in hospitals
20. A Systems Approach to Strategic IS Integration
21. Protocol for: Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR.
22. 562: Elexacaftor/tezacaftor/ivacaftor in children aged 6 and older with cystic fibrosis and at least 1 F508del allele: Interim results from a Phase 3 open-label extension study
23. Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis
24. Seeing Fog Clearly: The C-FOG Research Program Addresses Predictability
25. C-FOG Life of coastal fog
26. Realising opportunities for evidence-based cancer service delivery and research: linking cancer registry and administrative data in Australia
27. The wheezing infant
28. Dependence of smooth muscle tone upon pulsatility in the iliac artery of the anaesthetised pig
29. S63 Ivacaftor in 4- to <6-month-old infants with cystic fibrosis and a gating mutation: results of a 2-part, single-arm, Phase 3 study
30. The use of air displacement plethysmography in children and adolescents with cystic fibrosis
31. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening
32. PROSPECTIVE EVALUATION OF RESPIRATORY EXACERBATIONS IN CHILDREN WITH CYSTIC FIBROSIS FROM NEWBORN SCREENING TO 5 YEARS OF AGE (FOR ACFBAL STUDY GROUP): 360★
33. AUSTRALASIAN CF BRONCHOALVEOLAR LAVAGE (ACFBAL) STUDY: P. AERUGINOSA (PA) GENOTYPES IN PRE-SCHOOL CF CHILDREN: 299
34. LONG-TERM SAFETY AND EFFICACY OF INVESTIGATIONAL CFTR POTENTIATOR, VX-770, IN SUBJECTS WITH CF: 204
35. ▪ ARTHROPLASTY Age at hip or knee joint replacement surgery predicts likelihood of revision surgery
36. Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time PCR and high-resolution melting curve analysis
37. FRACTURED NECK OF FEMUR: STATE OF A NATION
38. PLEURAL FLUID NUCLEIC ACID TESTING ENHANCES PNEUMOCOCCAL SURVEILLANCE IN CHILDREN: TP-144
39. An Open-Label Extension (OLE) study of Tezacaftor/Ivacaftor (TEZ/IVA) in patients (PTS) ≥ 12 years with cystic fibrosis (CF) Homozygous for F508DEL-CFTR (F/F) or Heterozygous for F508DEL-CFTR and a residual function mutation (F/RF)
40. Guidelines for reporting experiments involving animals: the ARRIVE guidelines
41. MINIMUM 10 YEAR REVIEW OF RESPIRATORY FUNCTION POST CORRECTION IN IDIOPAT HIC SCOLIOSIS PATIENTS: A CLINICAL FOLLOW UP AND LITERATURE REVIEW.
42. THE SURVIVAL OF HIP AND KNEE REPLACEMENTS AND PATIENTS: THE DUNEDIN EXPERIENCE
43. Studies on drug combinations in acute myocardial ischaemia with emphasis on beta-adrenoceptor blocking agents and thromboxane synthetase inhibitors
44. Studies in compounds related to steroidal hormones
45. Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis
46. Editorial
47. Mast cell degranulation – a mechanism for the anti-arrhythmic effect of endothelin-1?
48. The Morscher Press Fit acetabular component: A NINE- TO 13-YEAR REVIEW
49. Mast cells, peptides and cardioprotection - an unlikely marriage?
50. IMPROVING SELF-EFFICACY IN ADOLESCENTS AND YOUNG ADULTS WITH CYSTIC FIBROSIS: TP 113
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.